Overcoming Pediatric Trial Challenges

Since the enactment of the FDA Safety and Innovation Act (FDASIA) in 2012, the demand for pediatric clinical trials has increased. Pediatric trials are specialized and unique, and they are becoming more popular, particularly with companies that want to extend their patents to include pediatric patents. According to the FDA, only about 20 percent of drugs have been labeled for pediatric patients. The potential is high to get new drugs approved for use in pediatrics. And QPS is pleased to support its partners in conducting pediatric clinical trials to test how drugs work in children.

As the number of pediatric trials being conducted increases, there are several challenges confronting parents, guardians, patients and pharmaceutical companies. One of the biggest of these issues is that it is difficult to enroll participants in pediatric trials. However, these five strategies can help make it easier to enroll trial participants and complete successful trials.